Home Shop 4-Hydroxyphenylretinamide

4-Hydroxyphenylretinamide

BML-GR103

Datasheet
Manual
SDS
CofA

Already have an account?

Retinoic acid receptor ligand

An analog of all trans retinoic acid that shows antiproliferative activity on cultured human breast cancer cells. Highly selective activator of retinoid receptors. Induces apoptosis in malignant hemopoietic cell lines.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Product Details

Alternative Name	Fenretinide
Appearance	Orange solid.
CAS	65646-68-6
Couple Target	Retinoic acid receptor
Couple Type	Ligand
Formula	C₂₆H₃₃NO₂
MW	391.5
Purity	≥97% (TLC)
Solubility	Soluble in DMSO (25mg/ml) or 100% ethanol (25mg/ml).
Source	Synthetic.

Handling & Storage

Use/Stability	As indicated on product label or CoA when stored as recommended.
Long Term Storage	-20°C
Shipping	Blue Ice

Regulatory Status	RUO – Research Use Only

Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses: F.S. Varghese, et al.; Antiviral Res. 126, 117 (2016), Application(s): Cell culture, Abstract
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors: A. N. Fanjul, et al.; J. Biol. Chem. 271, 22441 (1996), Abstract — Full Text
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation: M. Ponzoni, et al.; Cancer Res. 55, 853 (1995), Abstract — Full Text
N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid: D. Delia, et al.; Cancer Res. 53, 6036 (1993), Abstract
Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors: C. J. Grubbs, et al.; Anticancer Res. 10, 661 (1990), Abstract
Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells: C. Marth, et al.; J. Natl. Cancer Inst. 75, 871 (1985), Abstract

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Datasheet

Certificate of Analysis

Please enter the lot number as featured on the product label

Lot No. :

SDS

Enzo Life Science provides GHS Compliant SDS

If your language is not available please fill out the SDS request form

Your Cart

Your Cart

4-Hydroxyphenylretinamide

BML-GR103

Product Details

Handling & Storage

Datasheet, Manuals, SDS & CofA

Manuals And Inserts

Certificate of Analysis

SDS

Change Country

Tell us about You

Tell us about your paper

Tell us about You

Tell us about your project